Gene Query: TMED3

Dataset Description Geneva Score
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 77.1
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 36.76
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 25.76
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 25.28
hnRNP C is a key regulator of protein synthesis in mitosis 23.22
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 21.75
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 21.56
TCF7L1 knockdown in pancreatic cancer 20.37
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 19.37
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 19.37
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 19.25
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 19.04
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 18.93
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 18.93
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 18.9
RNA-Seq analysis of breast cancer cells after shikonin treatment 17.4
The comparison of high-throughput single-cell RNA-seq methods 16.62
Mitochondrial dsRNA triggers antiviral signalling in humans 16.54
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 15.44
Genome-wide analysis of the Integrator complex (HTS) 14.97
Genome-wide analysis of the Integrator complex 14.97
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 14.94
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 14.86
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 14.75
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 14.71
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 14.53
Lipid degradation promotes prostate cancer cell survival 14.52
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 14.14
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 14.12
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 14.11
RNA expression analysis upon JMJD1C depletion 14.06
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 14.06
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 14.06
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 13.87
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 13.87
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 13.83
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 13.73
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 13.55
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 13.43
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 13.37
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 13.32
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 13.29
Functional role of SLIT2 and ROBO1 in trophoblasts 13.19
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 13.15
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 13.08
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 12.96
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 12.71
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 12.59
Morphological and molecular characterization of human dermal lymphatic collectors 12.56
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 12.26
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 12.26
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 12.25
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 12.25
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 12.2
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 11.97
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 11.97
The role of FAM46C in myeloma cells 11.78
The role of FAM46C in myeloma cells [sequencing] 11.78
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 11.68
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 11.68
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 11.67
circRNA-sequencing 11.59
Control of prostate tumour growth by the long non-coding RNA GHSROS 11.56
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 11.52
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 11.52
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 11.51
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 11.33
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 11.33
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 11.33
Hijacking of stress response machinery by oncogenes in acute leukaemia 11.25
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 11.25
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 11.13
SRSF2 mutations impair hematopoiesis and alter exon recognition 11.0
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 10.91
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 10.91
Changes in human endometrial gland transcriptome over the window of implantation 10.9
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 10.64
Identifying the molecular mode of action of itraconazole in colorectal cancer 10.57
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 10.57
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 10.43
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 10.41
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 10.41
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 10.39
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 10.39
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 10.3
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 10.25
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 10.18
Effect of mitochondria deficiency on senescence-associated gene expression 10.15
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 10.11
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 10.07
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 10.02
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 10.01
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 10.01
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 9.95
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 9.88
METTL3 promotes translation in human cancer cells 9.79
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 9.78
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 9.76
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 9.72
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 9.72
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 9.71
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 9.57
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 9.57
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 9.55
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 9.55
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 9.48
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 9.42
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 9.42
DJ-1 is dispensable for human stem cell homeostasis 9.4
Modeling Familial Cancer with iPSC Approaches 9.36
The human blood-nerve barrier transcriptome 9.35
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 9.31
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 9.31
Total RNA-seq in ALL-SIL upon JQ1 inhibition 9.28
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 9.26
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 9.17
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 9.13
Loss of endometrial plasticity in recurrent pregnancy loss 9.13
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 9.13
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 9.13
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 9.11
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 9.11
Transcriptomic analysis of the HOTAIR-regulated genes 9.06
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 9.03
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 9.02
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 9.01
IDH3a KO RNA-seq 8.96
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 8.9
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 8.9
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 8.82
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 8.81
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 8.79
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 8.76
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 8.76
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 8.66
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 8.66
Transcriptome analysis in Neobractatin treated cells 8.65
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 8.49
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 8.49
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 8.45
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 8.45
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 8.44
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 8.44
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 8.39
High-Throughput Kinetic Analysis of Fractional Killing 8.36
STRIPAK directs PP2A activity to promote oncogenic transformation 8.27
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 8.25
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 8.25
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 8.24
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 8.24
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 8.21
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 8.17
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 8.13
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 8.09
High level DNA repair gene expression in human ES cells 8.06
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 8.04
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 8.01
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 8.01
Exploring the RNA landscape of endothelial exosomes 8.0
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 7.95
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 7.93
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 7.88
RNA Seq of HMVEC under hypoxia 7.88
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 7.86
Postnatal lipids drive hepatocyte maturation 7.84
Cerebellar differentiation in Ataxia-Telangiectasia 7.83
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 7.82
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 7.81
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 7.8
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 7.79
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 7.79
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 7.78
Reassessment of Exosome Composition 7.77
RNA expression following TMPRSS11B overexpression or depletion 7.77
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 7.76
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 7.74
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 7.69
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 7.69
Tracking distinct RNA populations using efficient and reversible covalent chemistry 7.68
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 7.66
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 7.66
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 7.66
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 7.66
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 7.62
Disruption of the exocyst induces podocyte loss and dysfunction 7.57
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 7.57
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 7.56
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 7.56
Human Treg IL-12 stimulation 7.56
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 7.55
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 7.5
Comprehensive comparative analysis of 5’ end RNA sequencing methods 7.49
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 7.4
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 7.4
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 7.36
scRNASeq analysis of cycling cardiomyocytes 7.34
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 7.29
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 7.28
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 7.27
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 7.25
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 7.25
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 7.22
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 7.22
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 7.22
DECIDUALIZATION INDUCES A SECRETOME SWITCH IN THE PERIVASCULAR NICHE CELLS OF THE HUMAN ENDOMETRIUM 7.21
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 7.19
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 7.17
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 7.14
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 7.12
ARS2 is a general suppressor of pervasive transcription [RNAseq] 7.06
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 7.05
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 7.04
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 7.04
Ebola virus (EBOV) infection of ARPE-19 cells 7.03
3’ Uridylation Expands miRNA Target Repertoire 7.01
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 7.0
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 6.98
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 6.95
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 6.93
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 6.93
Altering cancer transcriptomes using epigenomic inhibitors 6.91
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 6.91
Identification of long noncoding RNAs regulated by p53 6.88
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 6.87
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 6.83
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 6.82
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 6.8
Gene expression profiling of human and murine in vitro muscle differentiation 6.63
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 6.6
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 6.53
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 6.53
Identification of transcription start sites for human A549 cell line using ReCappable-seq 6.51
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 6.49
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 6.49
Identification of HOXB13 target genes responsive to BET inhibitors 6.43
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 6.36
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 6.34
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 6.31
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 6.3
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 6.29
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 6.27
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 6.24
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  6.21
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 6.21
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 6.21
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 6.21
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 6.17
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 6.13
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 6.12
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 6.11
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 6.09
Human HAP1 cells before and after nutrient deprivation 6.09
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 6.07
RNA-sequencing of human tendon after injury 6.05
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 5.99
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 5.98
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 5.98
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 5.97
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 5.94
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 5.93
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 5.92
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 5.92
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 5.87
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 5.87
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 5.84
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 5.84
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 5.82
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 5.75
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 5.75
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 5.74
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 5.74
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 5.74
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 5.73
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 5.72
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 5.72
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 5.67
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 5.57
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 5.5
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 5.49
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 5.38
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 5.26
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 5.24
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 5.24
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 5.22
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 5.2
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 5.18
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 5.12
HEK293 TFAM Knockout Expression Study 5.07
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 5.06
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 5.06
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 5.03
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 5.02
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 5.0
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 4.98
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 4.98
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 4.98
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 4.97
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 4.97
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 4.91
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 4.89
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 4.85
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 4.79
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 4.79
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 4.79
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 4.79
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 4.75
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 4.73
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 4.62
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 4.54
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 4.52
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 4.51
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 4.51
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp1] 4.47
SRSF1 role in cellular gene expression and splicing 4.47
RNA sequencing analysis of selumetinib-resistant CRC cells lines 4.42
Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor 4.42
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 4.39
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 4.37
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 4.37
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 4.36
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 4.34
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 4.25
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 4.18
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 4.16
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 4.13
Intrahepatic MAIT cell gene expression revealed by RNA-seq 4.11
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 4.1
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 4.07
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 4.07
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 4.03
Transcriptome landscape of HeLa response upon triamcinolone acetonide 4.0
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 4.0
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 4.0
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 3.92
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 3.91
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 3.83
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 3.81
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 3.77
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 3.69
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 3.63
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 3.44
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 3.42
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 3.42
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 3.38
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 3.34
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 3.3
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 3.28
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 3.26
Transcriptomic analysis of human macrophages in 3D 3.25
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 3.22
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 3.2
TAF1 is critical for AE driven leukemogenesis 3.17
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 3.17
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 3.05
NAPRT activation of macrophages 3.03
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 3.02
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 2.88
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 2.85
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 2.85
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 2.84
RNA-seq of RKO cells with cTAZ KO or putback 2.83
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 2.73
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 2.72
Transcriptome sequencing of K-562 cells 2.67
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 2.66
Identification of a LIF-responsive replication-competent human β cell 2.62
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 2.61
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 2.6
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 2.57
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 2.57
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 2.53
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 2.53
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 2.48
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 2.45
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 2.44
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 2.42
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 2.42
Profiling of escape kinetics of viruses subjected to RNAi 2.4
Tracing Enhancer Networks using Epigenetic Traits (TENET) 2.37
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 2.33
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 2.32
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 2.31
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 2.3
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 2.22
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 2.19
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 2.17
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 2.14
Interaction between mitoNEET and NAF-1 in cancer cells 2.13
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 2.12
m6A-dependent regulation of messenger RNA stability 2.11
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 2.06
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 2.05
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 2.05
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 2.02
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 2.0
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 2.0
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 1.99
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 1.92
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 1.91
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 1.89
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 1.89
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 1.83
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 1.83
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 1.79
A single-cell transcriptome atlas of the human pancreas 1.77
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 1.74
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 1.69
Hepatic transcriptome of pediatric hepatoblastoma. 1.67
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 1.65
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 1.65
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 1.64
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 1.53
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 1.53
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 1.49
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 1.48
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 1.48
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 1.48
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 1.48
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 1.47
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 1.45
Necroptosis inhibition protects from dopaminergic neuronal cell death in OPA1 mutant Parkinson’s disease patient neurons and MPTP treated mice 1.44
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 1.43
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 1.39
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 1.38
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 1.37
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.36
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 1.32
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells II 1.3
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 1.29
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 1.27
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 1.26
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 1.22
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 1.22
Transcriptome profiling of A2M treated A549 Cell Line Samples 1.22
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 1.22
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 1.22
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 1.19
Expression profiling of MCF-7 cells with treatment of TCDD 1.16
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 1.16
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 1.16
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 1.14
Enhancer activation during EGF response 1.08
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 1.08
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 1.06
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 1.03
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.94
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.9
CD86 regulates a pro-survival signal in myeloma cells 0.89
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 0.86
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.84
0.82
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.8
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 0.79
RNAseq of cell lines with knocked in ESR1 mutations 0.76
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 0.74
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 0.74
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 0.72
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 0.71
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 0.71
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.67
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 0.65
Ribosome profiling upon inhibition of eIF4A 0.64
RNA seq_PDX2_SHP099 0.63
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.62
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 0.62
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 0.6
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 0.59
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 0.59
Epigenomic conservation of transposable element silencing 0.54
Epigenomic conservation of transposable element silencing [RNA-seq] 0.54
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 0.51
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] 0.49
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.44
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.39
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 0.35
Iron response of HepG2 cells 0.35
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 0.29
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 0.21
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.2
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.18
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 0.16
BMS-470539 on human synovial fibroblasts 0.16
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.15
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 0.14
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.14
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.14
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 0.13
Glucose inhibits cardiac maturation through nucleotide biosynthesis 0.1
Human Tfh cell RNA bulk sequencing 0.09
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.09
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 0.09
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.05
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 0.05
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 0.04
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.04
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.04
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 0.04
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.02
p63 controls the enhancer landscape during keratinocyte differentiation 0.01
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation